Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Research Abstract |
In summary, we have demonstrated that Early Growth Response Protein (Egr)-1 up-regulates the expression of VEGF-A in lung cancer cells by binding at specific sites in the VEGF-A promoter and that NAB2, a Egr-1 corepressor, probably form a negative feedback system for the Egr-1-VEGF-A expression. Egr-1 and NAB-2 may be useful as novel pharmaceutical targets in lung cancers.
|